Chubb Ltd’s Ptc Therapeutics Inc Position
Does Chubb Ltd own Ptc Therapeutics Inc (PTCT)? Yes — 8.2K shares worth $312,231 (+1.04% of its 13F portfolio) as of Q4 2022.
Position Value
$312,231
Q4 2022
Shares
8.2K
% of Portfolio
+1.04%
Quarters Held
17
currently held
Position History PTCT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2022 | 8.2K | $312,231 | +1.04% |
| Q3 2022 | 8.2K | $411,000 | +1.52% |
| Q2 2022 | 8.2K | $328,000 | +1.32% |
| Q1 2022 | 8.2K | $305,000 | +0.76% |
| Q4 2021 | 8.2K | $326,000 | +0.72% |
| Q3 2021 | 8.2K | $304,000 | +100.00% |
| Q2 2021 | 8.2K | $346,000 | +1.23% |
| Q1 2021 | 8.2K | $387,000 | +1.10% |
| Q4 2020 | 8.2K | $499,000 | +0.47% |
| Q3 2020 | 8.2K | $382,000 | +7.47% |
| Q2 2020 | 8.2K | $415,000 | +1.47% |
| Q1 2020 | 8.2K | $365,000 | +1.80% |
| Q4 2019 | 8.2K | $393,000 | +1.68% |
| Q3 2019 | 8.2K | $277,000 | +1.29% |
| Q2 2019 | 8.2K | $368,000 | +1.82% |
| Q1 2019 | 8.2K | $308,000 | +0.21% |
| Q4 2018 | 8.2K | $281,000 | +0.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chubb Ltd’s full portfolio or all institutional holders of PTCT.